Detection of Helicobacter pylori antigen in stool samples for diagnosis of infection in children
M. Rafeey1 and S. Nikvash2
اختبار الكشف عن مستضدات الملويَّة البوابيَّة في عينات البراز لتشخيص العدوى لدى الأطفال
ماندانا رفيعي، سولماز نيكوش
الخلاصـة:
قام الباحثان بإجراء هذه الدراسة لتقييم اختبار مستضدي غير باضع يجرى على عينات البراز، لتشخيص العدوى بجراثيم الملويَّة البوابيَّة في الأطفال، مقارنةً بالاختبار الهستوباثولوجي الذي يجرى على الخزعات المعوية (المعيار الذهبي). وشملت الدراسة 96 طفلاً تراوحت أعمارهم بين عام واحد وخمسة أعوام، ممن كانوا يعانون من أعراض عسر الهضم وأحيلوا لإجراء تنظير داخلي في مستشفى الأطفال في تبريز، بجمهورية إيران الإسلامية، في الفتـرة من أيار/مايو 2003 وحتى آذار/مارس 2004. وجاءت نتائج الاختبار المستضدي في عينات البراز إيجابية لدى 34 طفلاً من بين 62 طفلاً أثبت اختبار النسيج المعوي إيجابيتهم لعدوى الملوية البوابية، كما جاءت نتائج اختبار عينة البراز سلبية لدى 27 من بين 34 مريضاً ممن كانت نتائج اختبار النسيج لديهم سلبية. وأظهرت النتائج انخفاض معدلات الحساسية والنوعية في هذا الاختبار (54.8% و79.4% على التوالي)، بالمقارنة بالمعيار الذهبي. كما بلغت القيمة التكهّنية السلبية 82.9% و49.9%. ومع ذلك فإن استخدام هذا الاختبار قد يكون مفيداً في مجال التحري الجموعي لجرثومة الملوية البوابية.
ABSTRACT: The study evaluated a non-invasive antigen test of stool samples for the diagnosis of Helicobacter pylori infection in children compared with histopathology of gastric biopsies (gold standard). The study included 96 children aged 1–15 years old with dyspeptic symptoms referred for endoscopy at Tabriz Children’s Hospital, Tabriz, Islamic Republic of Iran from May 2003 to March 2004. Of 62 children who were positive by histology, 34 were H. pylori stool antigen positive and of 34 patients with negative histology, 27 had negative stool test. The sensitivity and specificity of the test were low (54.8% and 79.4% respectively) compared with the gold standard and the positive and negative predictive values were 82.9% and 49.9%. However, the test may be useful for mass screening for H. pylori.
Détection de l'antigène fécal d'Helicobacter pylori pour le diagnostic de l'infection chez
l'enfant
RÉSUMÉ: Cette étude a évalué un test non invasif de détection de l’antigène fécal d’Helicobacter
pylori (HpSA - pour Helicobacter pylori stool antigen) chez l’enfant versus l’histopathologie de biopsies gastriques (la norme en l’espèce). Ont été inclus dans l’étude 96 enfants âgés de 1 à 15 ans adressés entre mai 2003 et mars 2004 à l’hôpital pour enfants de Tabriz, en République islamique d’Iran, pour endoscopie sur présentation de symptômes dyspeptiques. Sur les 62 enfants positifs à l’histologie, 34 se sont avérés HpSA‑positifs tandis que sur les 34 patients présentant une histologie négative 27 étaient HpSA‑négatifs. Comparativement au test de référence, ce test antigénique a fait preuve d’une sensibilité et d’une spécificité peu convaincantes, à savoir respectivement 54,8 % et 79,4 %, les valeurs prédictives positive et négative étant quant à elles de 82,9 % et 49,9 %. Toutefois, ce test peut avoir son utilité dans le cadre d’un dépistage de masse d’Helicobacter pylori.
1Department of Paediatric Gastroenterology, Liver and Gastrointestinal Diseases Research Centre; 2Department of Microbiology, Children’s Hospital, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran (Correspondence to M. Rafeey: mrafeey@yahoo.com).
Received: 22/07/05; accepted: 13/11/05
Introduction
Gastric and ulcer peptic disease is a common disease
in the community, especially in children. Considering the close relationship
between peptic ulcer and gastritis caused by Helicobacter pylori, the
accurate and early diagnosis of infection by this micro-organism is very
important so as to provide prompt and convenient treatment to the affected
children [1,2]. The diagnostic tests for H. pylori infection are
principally of 2 types: invasive and non-invasive. Invasive diagnostic methods
include polymerase chain reaction (PCR), rapid urease test (RUT), endoscopy of
the upper digestive tract and biopsy of the gastric mucosa for pathological
examination. Non-invasive diagnostic methods include serologic enzyme-linked
immunosorbent assay (ELISA), urea breath test (UBT) with C13 or C14 labelled
urea and the
H.
pylori stool antigen test (HpSA) [1–4].
No study is
available from the East Azerbaijan area or elsewhere in the Islamic Republic of
Iran to compare the results of invasive and non-invasive diagnostic methods for
detecting of H. pylori antigen in stool samples in children in the
community. This
research study was therefore carried out to ascertain whether detection of H.
pylori antigen in the stool sample using immuno-assay can substitute for
diagnostic tests such as endoscopy and biopsy of the gastric mucosa, which,
although standardized, are painful procedures that may involve a high level of
risk, especially in children.
Methods
The study design was observational, descriptive with
convenience sampling.
Sample
The study was carried out on all children aged from
1–15 years old with dyspeptic symptoms who were referred to the endoscopic
section of Tabriz children’s hospital during an 11-month period from May 2003 to
March 2004. The children were included if they suffered dyspepsia, chronic
gastric pain (gastric pain for more than 3 months with at least one course of
pain each month), recurrent anorexia, vomiting and heartburn, bleeding in the
upper or lower digestive tract and recurrent diarrhoea. Patients with severe
diarrhoea and those who had received antibiotics or proton pump inhibitors as
well as antacids in the previous 4 weeks were excluded from the study.
The children and
their parents were informed about the necessary clinical and laboratory
examination procedures and their consent was taken before the start of the
study.
Data collection
Endoscopy of the digestive system was performed by
video endoscopy (Olympus
video-gastroscope Evis 100 type
XP 20). A total of 3 biopsy samples were taken from observation areas and sent
to the pathology laboratory: 2 from the antrum at 2 cm intervals and 1 from the
gastric corpus. Histological preparations were done under haematoxylin–eosin
stain and also by modified May–Grunwald–Giemsa staining procedure. The presence
of H. pylori organisms was reported in 6 groups ranging from grade 0 to
grade 5 using the modified scoring system (MSS) criteria for assessing
histopathology samples [5].
Stool samples for
the HpSA
test were taken from patients and sent to the
microbiology laboratory. Detection of H. pylori antigens in stool was
carried out by ELISA polyclonal antibody test (Equipar HpSA test, Saronno,
Italy).
Analysis
After gathering simple frequencies and percentages,
the data were transferred to computer and analysed by SPSS using McNamara
test and the chi-squared test. Sensitivity, specificity and positive and
negative predictive values were calculated using the histopathology results as
the gold standard.
Results
The study group was 96 children aged from 1–15 years
old with a mean age of 8.3 years (standard deviation 0.3 years); 70 (72.9%) were
outpatients and 26 (27.1%) were admitted as inpatients in the gastroenterology
division or other divisions of the children’s hospital. There were 65 males
(67.7%) and 31 females (32.3%).
Table 1 shows the
results of histopathology examination of biopsy specimens from the gastric
areas. The results of the HpSA antigen test in stool samples of
patients are shown in Table 2.


Comparing the
incidence of H. pylori cases from biopsy and stool testing, it was found
that out of 62 (64.6%) patients reported positive for H. pylori in
histopathology of biopsy samples (the gold standard), only 34 cases were H.
pylori positive by the HpSA
test (Table 3). According to this study, the
sensitivity, specificity, positive and negative predictive values for the HpSA
test were 54.8%, 79.4%, 82.9% and 49.9%
respectively. There was a significant difference between the 2 groups who were
positive for H. pylori in biopsy sample and negative for H. pylori
in biopsy in terms of H. pylori variance in the HpSA test
(P < 0.001, McNamara test).

Table 4 presents
the H. pylori histopathology grading in biopsy samples based on
MSS criteria and the HpSA positive cases. It was observed
that as the grade of H. pylori in biopsy samples increased, the
possibility of the stool sample being positive increased too (P < 0.001).
Out of 31
patients whose histological examination indicated grade 2 or 3, less than of
half cases (n = 14) were H. pylori negative in stool samples. The
most important finding was that all of 9 patients determined as grade 4 or 5
from biopsy samples were also H. pylori positive in stool samples (Table
4).
In
addition, out of all 34 cases of grade 0 of H. pylori in biopsy sample,
27 cases were reported H. pylori negative.

Discussion
To determine H. pylori infection in humans,
multiple laboratory methods have been reported [5–8]; however, based on
estimated resources, the histological examination of biopsy samples is
considered as the gold standard among invasive diagnostic methods to diagnose
this micro-organism with a sensitivity and specificity of 100% [2].
In comparison to
biopsy, cultivation of bacteria requires specific environmental conditions and a
fairly long time for the organism to grow, which are considered as the
shortcomings of the biopsy cultures, although the rate of success is reported to
be nearly 100% when there is accuracy in the cultivation of biopsy samples [2].
Other invasive procedures, the RUT and antibody measurements in blood using
ELISA are less sensitive and specific in children as compared with adults [1,2].
The UBT is a
non-invasive method that possesses more accuracy to diagnose infectious from
non-infectious cases in children and adults and is reported to be 100% sensitive
and 92% specific in diagnosing H. pylori infection in children. However,
the test is difficult to perform in children and require the child’s
collaboration [2].
According to a
study in Taiwan, 53 children affected by dyspepsia were assayed [6]. The
diagnostic accuracy of different tests was as follows: culture 98.1%, RUT 96.2%,
pathology 98.1%, PCR 94.3%, serology 84.9%, UBT 100% and HpSA 96.2%. According to their study, all the
above-mentioned methods, except serology, are considered valuable diagnostic
methods in the diagnosis of H. pylori in children [6]. This and
similar studies in Germany, China, France, England, Spain, Italy and Poland
revealed that non-invasive methods such as HpSA possess high sensitivity and
specificity as compared with other diagnostic methods in children such as UBT [7–15].
In another study
in England, the results of detection of HpSA were compared in 72 patients
suffering from dyspepsia using 3
stool antigen enzyme immunoassay kits
versus endoscopy biopsy samples
[16].
The
sensitivity of the
Premier
Platinum Hp SA kit (Meridian Diagnostics, Cincinnati, Ohio, USA)
was 63.6% and
specificity 92.6%, the sensitivity of
FemtoLab Cnx
kit (Dako, Ely, Cambridgeshire, UK)
was 88% and
specificity 97.6%, and the sensitivity of the
Hp Ag kit (Dia.Pro,
Milan, Italy)
was 56% and
specificity 97.6% [16].
Our study was an
HpSA test using polyclonal antibody detected by ELISA and the sensitivity and
specificity were 54.8% and 79.4% respectively. Our results are compatible with
the above study [16] but not with the results of the study in Taiwan [6].
Despite minor difficulties such as the collection of a new stool sample, the
performance of HpSA is an alternative and reliable substitute for the UBT test
as a non-invasive diagnostic method in children. Secondly, the test is not
expensive and does not require a blood sample.
Considering the
sensitivity and specificity of the HpSA test in our study, the practical value
of this test seems to lie more in eliminating cases that are negative for H.
pylori and accordingly this test could be applied in mass screening such as
at regional school level.
Acknowledgements
The authors wish to thank the office of the
Vice-Chancellor for Research of Tabriz University of Medical Sciences for the
financial assistance and Dr Hasani and Ms Anbarshahi for preparation of this
article.
References
-
Sylvester FA. Peptic ulcer disease. In:
Behrman RE, Kilgman RM, Jenson HB, eds. Nelson textbook of pediatrics,
17th ed. Philadelphia, WB Saunders, 2004:1244–7.
-
Rowland M, Bourke B, Drumm B. Gastritis and peptic ulcer
disease. In: Walker WA et al., eds. Pediatric gastrointestinal disease,
3rd ed. Ontario, BC Decker, 2000:385–92.
-
Antonioli DA, Odze RD. Gastritis in infants and children. In:
Graham DY, Genta RM, Dixon MF, eds. Gastritis. Philadelphia,
Lippincott, Williams and Wilkins, 1999.
-
Triantafyllopoulou M,
ed.
Helicobacter pylori infection. eMedicine [online article]
(http://www.emedicine.com/ped/topic938.htm, accessed 16 March 2007).
-
Sheu BS et al.
Bacterial density of Helicobacter pylori predicts the success of
triple therapy in bleeding duodenal ulcer. Gastrointestinal endoscopy,
1996, 44:683–8.
-
Ni YH et al. Accurate diagnosis of Helicobacter pylori
infection by stool antigen test and 6 of other current available tests in
children. Journal of pediatrics, 2000, 136(6):823–7.
-
Braden B et al. New immunoassay in stool provides an accurate
noninvasive diagnostic method for Helicobacter pylori screening in
children. Pediatrics, 2000, 106:115–7.
-
Shepherd AJ et al.
Comparison of
an enzyme immunoassay for the detection of Helicobacter pylori
antigens in the faeces with the urea breath test.
Archives of disease in childhood, 2000, 83(3):268–70.
-
Husson MO et al.
Evaluation of
a Helicobacter pylori stool antigen test for the diagnosis and
follow-up of infections in children. European
journal of clinical microbiology & infectious diseases, 2000,
19(10):787–9.
-
Gonzalez-Cuevas A et al.
Infecciones
por Helicobacter pylori: deteccion de antigeno en muestras fecales
[Helicobacter
pylori infections: antigen detection in stool samples]. Enfermedades
infecciosas y microbiologia clinica, 2001, 19(2):49–52.
-
Sykora J et al.
Presna
neinvazivni diagnostika infekce Helicobacter pylori pomoci stanoveni
antigenu ve stolici v detske populace [Accurate noninvasive diagnosis of
Helicobacter pylori infection using antigen determination in the feces
in the pediatric population]. Casopis lekaru ceskych,
2002, 141(13):425–7.
-
Roggero P et al. Helicobacter pylori stool antigen
test: a method to confirm eradication in children. Journal of pediatrics,
2002, 140:775–7
-
Van Doorn OJ et al. Helicobacter pylori stool antigen
test: a reliable non-invasive test for the diagnosis of Helicobacter
pylori infection in children. European journal of gastroenterology &
hepatology, 2001, 13(9):1061–5.
-
Koletzko S et al. Evaluation of a novel monoclonal enzyme
immunoassay for detection of Helicobacter pylori antigen in stool
from children. Gut, 2003, 52(6):804–6.
-
Sykora J et al.
Diagnostika
infekce Helicobacter pylori v detskem veku novou enzymoimunoanalytickou
metodou stanovenim antigenu ve stolici (HpStAR) pomoci monoklonalnich
protilatek [Diagnosis
of
Helicobacter
pylori
infection
in
childhood
with
a novel
immunoenzyme
method (HpStAR)
which
detects
antigens
in
feces
using
monoclonal
antibodies].
Casopis lekaru ceskych, 2003,
142(11):687–90.
-
Andrews J et al. Comparison of three stool antigen tests for
Helicobacter pylori detection. Journal of clinical pathology,
2003, 56:769–71.
|
Research policy and cooperation in the Eastern Mediterranean Region
The Research Policy and Cooperation (RPC) unit of the WHO Eastern
Mediterranean Region aims to support health research and development in
Member States of the Region through policy advice, capacity building of
national health research systems, generation of appropriate knowledge
and its utilization towards improved health.
RPC works in close collaboration with the technical units in the WHO
Eastern Mediterranean Regional Office as well as national focal points
for research or medical research councils and major health research
institutions in the Region and other national and international
partners.
Further information about the work RPC is available at: http://www.emro.who.int/rpc/index.htm |